Faces Delay in US FDA New Drug Submission For Duchenne Muscular Dystrophy Drug
https://www.marketscreener.com/quote/stock/SANTHERA-PHARMACEUTICALS-195471/news/Santhera-Updates-on-Ongoing-NDA-Submission-for-Vamorolone-40849711/
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.